Current Trends in Reproductive Health Epidemiology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Epidemiology & Public Health".

Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 3500

Special Issue Editor


E-Mail Website
Guest Editor
1. Maternal Fetal Medicine Service, Northwell Health, New York, NY, USA
2. Allen and Frances Adler Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY, USA
Interests: maternal fetal medicine; obstetric medicine; placenta-mediated complications; bleeding and thrombotic complications of pregnancy; preterm birth; perinatology;
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Reproductive epidemiology is a rapidly growing field focused on the distribution, determinants and sequelae of reproductive and/or perinatal events. It is driven both by the impact of living conditions early in life and in utero, and by the long-term health consequences following these exposures. An additional unique feature of studies in the field of reproductive epidemiology is the inclusion of families and not only single individuals, and such studies may extend over several generations. While reproductive epidemiologic research has made great contributions to improving human reproductive health in numerous areas, many other issues remain and must be addressed.

In this Special Issue of the Journal of Clinical Medicine, we are offering a platform to highlight the broad diversity of research performed across this field. This Special Issue will focus on new insights, current challenges and controversies, recent advances, and future perspectives in the field of reproductive epidemiology. We anticipate that the research presented will promote fruitful discussions in the reproductive epidemiology community that will translate to best practice applications in clinical, public health and policy settings.

Dr. Amihai Rottenstreich
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • reproductive health outcomes
  • maternal, paternal, perinatal and child health
  • conception, contraception and family planning
  • gynecologic, obstetric and postpartum health
  • infertility
  • reproductive equity

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 941 KiB  
Article
The Impact of Advanced Maternal Age on Pregnancy Outcomes: A Retrospective Multicenter Study
by Hila Hochler, Michal Lipschuetz, Yael Suissa-Cohen, Ari Weiss, Hen Y. Sela, Simcha Yagel, Joshua I. Rosenbloom, Sorina Grisaru-Granovsky and Misgav Rottenstreich
J. Clin. Med. 2023, 12(17), 5696; https://doi.org/10.3390/jcm12175696 - 1 Sep 2023
Cited by 2 | Viewed by 1489
Abstract
The aim of this multicenter retrospective cohort study was to examine the impact of maternal age on perinatal outcomes in multiparas, stratified according to maternal age in one- and two-year increments. The analysis involved 302,484 multiparas who delivered between the years 2003 and [...] Read more.
The aim of this multicenter retrospective cohort study was to examine the impact of maternal age on perinatal outcomes in multiparas, stratified according to maternal age in one- and two-year increments. The analysis involved 302,484 multiparas who delivered between the years 2003 and 2021 in four university-affiliated obstetrics departments. Maternal age was considered both as a continuous variable and in two-year intervals, as compared with a comparison group of parturients aged 25–30 years. The study focused on cesarean delivery and neonatal intensive care unit (NICU) admission as primary outcomes. The findings revealed that cesarean delivery rates increased as maternal age advanced, with rates ranging from 6.7% among 25–30 year olds, rising continuously from 13.5% to 19.9% between the age strata of 31 and 42, to exceeding 20% among those aged ≥ 43 years (p < 0.01 for each stratum when compared to 25–30 year old group). Similarly, NICU admission rates rose from 2.7% in the comparison group to 6% in parturients aged 45–46 years (p < 0.01 for each stratum when compared to 25–30 year old group). The study highlights the association between incrementally advanced maternal age and increased rates of maternal and neonatal complications, necessitating global awareness of these implications for family planning decisions and maternal care. Full article
(This article belongs to the Special Issue Current Trends in Reproductive Health Epidemiology)
Show Figures

Figure 1

12 pages, 1343 KiB  
Article
Investigation of the Prevalence of Diminished Ovarian Reserve in Korean Women of Reproductive Age
by Rihwa Choi, Wonseo Park, Gayoung Chun, Sang Gon Lee and Eun Hee Lee
J. Clin. Med. 2023, 12(15), 5099; https://doi.org/10.3390/jcm12155099 - 3 Aug 2023
Cited by 1 | Viewed by 1380
Abstract
Diminished ovarian reserve can be assessed biochemically using serum anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) tests. This study aimed to evaluate the prevalence of diminished ovarian reserve in a large population of reproductive-aged women by age and geographic region in Korea using [...] Read more.
Diminished ovarian reserve can be assessed biochemically using serum anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) tests. This study aimed to evaluate the prevalence of diminished ovarian reserve in a large population of reproductive-aged women by age and geographic region in Korea using different cutoffs of serum AMH and FSH levels. In 2022, 13,351 women underwent both AMH and FSH tests. The prevalence of diminished ovarian reserve increased markedly with age. Although cutoffs for AMH and FSH levels are different in USA and Korean guidelines, the overall prevalence of diminished ovarian reserve was comparable. The maximum prevalence was 3.8%, 6.0%, 11.0%, 28.6%, 69.3%, and 95.0% in women aged 20–24, 25–29, 30–34, 35–39, 40–44, and 45–49 years, respectively. The overall prevalence and age-adjusted prevalence of diminished ovarian reserve were 37.2% and 38.4%, respectively. Women who had only increased serum FSH without decreased AMH represented 1.1% (by Korean guidelines) and 2.5% (by USA guidelines) of all women. Serum AMH and FSH tests were underutilized on Jeju Island. The results of this study provide basic knowledge about diminished ovarian reserve for use in infertility support programs and the field of maternal aging. Full article
(This article belongs to the Special Issue Current Trends in Reproductive Health Epidemiology)
Show Figures

Figure 1

Back to TopTop